Premium
DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia
Author(s) -
Bailey Graham D.,
Qutob Haitham M. H.,
Akhtar Asma,
Russell Nigel H.,
Seedhouse Claire H.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15823
Subject(s) - nucleophosmin , npm1 , biology , frameshift mutation , dna damage , exon , microbiology and biotechnology , gene , cancer research , genetics , dna , karyotype , chromosome
X., Yang, S., Shen, J., Yang, Z., Chen, J. & Qian, C. (2018) Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB. British Journal of Haematology, 181, 360–371. Sabatino, M., Hu, J., Sommariva, M., Gautam, S., Fellowes, V., Hocker, J.D., Dougherty, S., Qin, H., Klebanoff, C.A., Fry, T.J., Gress, R.E., Kochenderfer, J.N., Stroncek, D.F., Ji, Y. & Gattinoni, L. (2016) Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies. Blood, 128, 519–528.